BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33917265)

  • 21. Th1 and Th2 cytokine profiles induced by hepatitis C virus F protein in peripheral blood mononuclear cells from chronic hepatitis C patients.
    Yue M; Deng X; Zhai X; Xu K; Kong J; Zhang J; Zhou Z; Yu X; Xu X; Liu Y; Zhu D; Zhang Y
    Immunol Lett; 2013 May; 152(2):89-95. PubMed ID: 23680070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TLR activation pathways in HIV-1-exposed seronegative individuals.
    Biasin M; Piacentini L; Lo Caputo S; Naddeo V; Pierotti P; Borelli M; Trabattoni D; Mazzotta F; Shearer GM; Clerici M
    J Immunol; 2010 Mar; 184(5):2710-7. PubMed ID: 20124101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+ T-cell proliferation in patients with hepatitis C virus infection.
    Della Bella S; Crosignani A; Riva A; Presicce P; Benetti A; Longhi R; Podda M; Villa ML
    Immunology; 2007 Jun; 121(2):283-92. PubMed ID: 17462079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcript analysis of P2X receptors in PBMCs of chronic HCV patients: an insight into antiviral treatment response and HCV-induced pathogenesis.
    Ashraf W; Manzoor S; Ashraf J; Ahmed QL; Khalid M; Tariq M; Imran M; Aziz H
    Viral Immunol; 2013 Oct; 26(5):343-50. PubMed ID: 24116708
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.
    Kamal SM; Rasenack JW; Bianchi L; Al Tawil A; El Sayed Khalifa K; Peter T; Mansour H; Ezzat W; Koziel M
    Gastroenterology; 2001 Sep; 121(3):646-56. PubMed ID: 11522749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.
    Berner B; Akça D; Jung T; Muller GA; Reuss-Borst MA
    J Rheumatol; 2000 May; 27(5):1128-35. PubMed ID: 10813277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus core protein induces homotolerance and cross-tolerance to Toll-like receptor ligands by activation of Toll-like receptor 2.
    Chung H; Watanabe T; Kudo M; Chiba T
    J Infect Dis; 2010 Sep; 202(6):853-61. PubMed ID: 20677943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune response of Th17-associated cytokines by peripheral blood mononuclear cells from patients with chronic hepatitis C virus infection.
    Cabral MS; Santos TPS; Santos PL; Schinoni MI; Oliveira IS; Pereira AB; Atta AM; Sousa-Atta MLB
    Cytokine; 2018 Feb; 102():200-205. PubMed ID: 28969940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct-acting antiviral drugs.
    Naveed M; Ali A; Sheikh N; Rafique S; Idrees M
    APMIS; 2020 Apr; 128(4):326-334. PubMed ID: 31863490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased frequency of interferon-gamma-producing peripheral blood CD4+ T cells in chronic hepatitis C virus infection.
    Kawakami Y; Nabeshima S; Furusyo N; Sawayama Y; Hayashi J; Kashiwagi S
    Am J Gastroenterol; 2000 Jan; 95(1):227-32. PubMed ID: 10638589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of toll-like receptor agonists and SARS-CoV-2 antigens on interferon (IFN) expression by peripheral blood CD3
    Abdolmohammadi-Vahid S; Baradaran B; Sadeghi A; Bezemer GFG; Kiaee F; Adcock IM; Folkerts G; Garssen J; Mortaz E
    Exp Mol Pathol; 2024 Jun; 137():104897. PubMed ID: 38691979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatitis C virus-specific T-cell reactivity during interferon and ribavirin treatment in chronic hepatitis C.
    Cramp ME; Rossol S; Chokshi S; Carucci P; Williams R; Naoumov NV
    Gastroenterology; 2000 Feb; 118(2):346-55. PubMed ID: 10648463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy.
    Ravens S; Hengst J; Schlapphoff V; Deterding K; Dhingra A; Schultze-Florey C; Koenecke C; Cornberg M; Wedemeyer H; Prinz I
    Front Immunol; 2018; 9():510. PubMed ID: 29616028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-Hepatic Depletion of Mucosal-Associated Invariant T Cells in Hepatitis C Virus-Induced Liver Inflammation.
    Bolte FJ; O'Keefe AC; Webb LM; Serti E; Rivera E; Liang TJ; Ghany M; Rehermann B
    Gastroenterology; 2017 Nov; 153(5):1392-1403.e2. PubMed ID: 28780074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Partial restoration of immune response in Hepatitis C patients after viral clearance by direct-acting antiviral therapy.
    Llorens-Revull M; Costafreda MI; Rico A; Guerrero-Murillo M; Soria ME; Píriz-Ruzo S; Vargas-Accarino E; Gabriel-Medina P; Rodríguez-Frías F; Riveiro-Barciela M; Perales C; Quer J; Sauleda S; Esteban JI; Bes M
    PLoS One; 2021; 16(7):e0254243. PubMed ID: 34242330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dynamic changes in programmed death-1 expression on the surface of T cells in chronic hepatitis C patients undergoing interferon therapy].
    Dong RQ; Zhou DF; Han R; Zhou JY; Zhao CY; Zhen Z
    Zhonghua Gan Zang Bing Za Zhi; 2013 Dec; 21(12):899-902. PubMed ID: 24636290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection.
    Holmes JA; Carlton-Smith C; Kim AY; Dumas EO; Brown J; Gustafson JL; Lauer GM; Silva ST; Robidoux M; Kvistad D; Alatrakchi N; Tonnerre P; Cohen DE; Zhang H; Shulman NS; Chung RT
    J Viral Hepat; 2019 Mar; 26(3):362-372. PubMed ID: 30450781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of direct-acting antiviral agents on the frequency of myeloid-derived suppressor cells and natural killer cells in patients with chronic hepatitis C.
    Li Y; Zeng Y; Zeng G; Li J; Zhang X; Cai Q; Chen Y; Lin CS
    J Med Virol; 2019 Feb; 91(2):278-286. PubMed ID: 30171691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance of T1 response as induced during PEG-IFNalpha plus ribavirin therapy controls viral replication in genotype-1 patients with chronic hepatitis C.
    Trapero M; García-Buey L; Muñoz C; Vitón M; Moreno-Monteagudo JA; Borque MJ; Quintana NE; Moreno-Otero R
    Rev Esp Enferm Dig; 2005 Jul; 97(7):481-90. PubMed ID: 16262527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative analysis of specific Th1/Th2 helper cell responses and IgG subtype antibodies in interferon-alpha-treated patients with chronic hepatitis C.
    Hempel G; Galle PR; Löhr HF
    J Med Virol; 2001 Jul; 64(3):340-9. PubMed ID: 11424124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.